Let’s start up with the current stock price of NexImmune Inc. (NEXI), which is $0.64 to be very precise. The Stock rose vividly during the last session to $0.6899 after opening rate of $0.5825 while the lowest price it went was recorded $0.58 before closing at $0.60.Recently in News on September 9, 2022, NexImmune to Present at the H.C. Wainwright 24th Annual Global Investment Conference. NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells, today announced that Kristi Jones, Chief Executive Officer, will present at the H.C. Wainwright 24th Annual Global Investment Conference on Monday, September 12 at 11:00 am ET. You can read further details here
NexImmune Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $4.9100 on 03/28/22, with the lowest value was $0.5703 for the same time period, recorded on 09/21/22.
NexImmune Inc. (NEXI) full year performance was -96.12%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, NexImmune Inc. shares are logging -96.35% during the 52-week period from high price, and 12.54% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.57 and $17.56.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1078955 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the NexImmune Inc. (NEXI) recorded performance in the market was -86.08%, having the revenues showcasing -70.69% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 18.56M, as it employees total of 74 workers.
The Analysts eye on NexImmune Inc. (NEXI)
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.6139, with a change in the price was noted -1.47. In a similar fashion, NexImmune Inc. posted a movement of -69.58% for the period of last 100 days, recording 1,158,815 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for NEXI is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical rundown of NexImmune Inc. (NEXI)
Raw Stochastic average of NexImmune Inc. in the period of last 50 days is set at 4.44%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 7.01%. In the last 20 days, the company’s Stochastic %K was 3.80% and its Stochastic %D was recorded 2.68%.
Considering, the past performance of NexImmune Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -86.08%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -75.69%, alongside a downfall of -96.12% for the period of the last 12 months. The shares increased approximately by -18.23% in the 7-day charts and went up by -44.19% in the period of the last 30 days. Common stock shares were lifted by -70.69% during last recorded quarter.